JP2025072507A5 - - Google Patents
Info
- Publication number
- JP2025072507A5 JP2025072507A5 JP2025017374A JP2025017374A JP2025072507A5 JP 2025072507 A5 JP2025072507 A5 JP 2025072507A5 JP 2025017374 A JP2025017374 A JP 2025017374A JP 2025017374 A JP2025017374 A JP 2025017374A JP 2025072507 A5 JP2025072507 A5 JP 2025072507A5
- Authority
- JP
- Japan
- Prior art keywords
- albumin binding
- amphiphilic
- lipid
- binding conjugate
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261620518P | 2012-04-05 | 2012-04-05 | |
| US61/620,518 | 2012-04-05 | ||
| JP2020099145A JP2020143165A (ja) | 2012-04-05 | 2020-06-08 | 免疫刺激組成物およびその使用方法 |
| JP2022165307A JP7631277B2 (ja) | 2012-04-05 | 2022-10-14 | 免疫刺激組成物およびその使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022165307A Division JP7631277B2 (ja) | 2012-04-05 | 2022-10-14 | 免疫刺激組成物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025072507A JP2025072507A (ja) | 2025-05-09 |
| JP2025072507A5 true JP2025072507A5 (cg-RX-API-DMAC10.html) | 2025-10-03 |
Family
ID=48083608
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504601A Active JP6375289B2 (ja) | 2012-04-05 | 2013-03-15 | 免疫刺激組成物およびその使用方法 |
| JP2017078218A Pending JP2017165739A (ja) | 2012-04-05 | 2017-04-11 | 免疫刺激組成物およびその使用方法 |
| JP2020099145A Pending JP2020143165A (ja) | 2012-04-05 | 2020-06-08 | 免疫刺激組成物およびその使用方法 |
| JP2022165307A Active JP7631277B2 (ja) | 2012-04-05 | 2022-10-14 | 免疫刺激組成物およびその使用方法 |
| JP2025017374A Pending JP2025072507A (ja) | 2012-04-05 | 2025-02-05 | 免疫刺激組成物およびその使用方法 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504601A Active JP6375289B2 (ja) | 2012-04-05 | 2013-03-15 | 免疫刺激組成物およびその使用方法 |
| JP2017078218A Pending JP2017165739A (ja) | 2012-04-05 | 2017-04-11 | 免疫刺激組成物およびその使用方法 |
| JP2020099145A Pending JP2020143165A (ja) | 2012-04-05 | 2020-06-08 | 免疫刺激組成物およびその使用方法 |
| JP2022165307A Active JP7631277B2 (ja) | 2012-04-05 | 2022-10-14 | 免疫刺激組成物およびその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US9107904B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP2833918B1 (cg-RX-API-DMAC10.html) |
| JP (5) | JP6375289B2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2731524T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013151771A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4032538A3 (en) | 2009-03-02 | 2022-10-26 | Massachusetts Institute of Technology | Methods and products for in vivo enzyme profiling |
| EP2525780B1 (en) | 2010-01-19 | 2022-09-07 | Northwestern University | Synthetic nanostructures including nucleic acids and/or other entities |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| JP6375289B2 (ja) | 2012-04-05 | 2018-08-15 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫刺激組成物およびその使用方法 |
| US9844582B2 (en) | 2012-05-22 | 2017-12-19 | Massachusetts Institute Of Technology | Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| EP2981284A1 (en) * | 2013-04-05 | 2016-02-10 | Kyushu University National University Corporation | Anti-tumor dna vaccine |
| JP6847660B2 (ja) | 2013-06-07 | 2021-03-24 | マサチューセッツ インスティテュート オブ テクノロジー | リガンドをコードする合成バイオマーカーのアフィニティベースの検出 |
| CA2919268C (en) | 2013-07-25 | 2023-09-05 | Exicure, Inc. | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use |
| US10568898B2 (en) | 2013-08-13 | 2020-02-25 | Northwestern University | Lipophilic nanoparticles for drug delivery |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| WO2015126502A2 (en) | 2013-12-03 | 2015-08-27 | Northwestern University | Liposomal particles, methods of making same and uses thereof |
| EP3129391A4 (en) * | 2014-04-03 | 2017-12-20 | Exicure, Inc. | Self assembling nucleic acid nanostructures |
| AU2015269412B2 (en) * | 2014-06-04 | 2020-03-12 | Exicure Operating Company | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| WO2016025647A1 (en) * | 2014-08-12 | 2016-02-18 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2, a therapeutic antibody, and a cancer vaccine |
| EP3183007B1 (en) | 2014-08-19 | 2020-06-17 | Northwestern University | Protein/oligonucleotide core-shell nanoparticle therapeutics |
| BR112017007012A2 (pt) | 2014-10-06 | 2018-03-06 | Exicure Inc | compostos anti-tnf |
| GB201418004D0 (en) * | 2014-10-10 | 2014-11-26 | Isis Innovation | Polymer adjuvant |
| CN104288758B (zh) * | 2014-10-22 | 2018-04-03 | 中国科学院生物物理研究所 | 聚乙二醇化磷脂为载体的胶束多肽疫苗 |
| WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| US10517924B2 (en) | 2014-11-24 | 2019-12-31 | Northwestern University | High density lipoprotein nanoparticles for inflammation |
| WO2016112963A1 (en) * | 2015-01-13 | 2016-07-21 | Riboxx Gmbh | Delivery of biomolecules into cells |
| EP3247796A4 (en) * | 2015-01-14 | 2018-07-11 | Exicure, Inc. | Nucleic acid nanostructures with core motifs |
| US10940201B2 (en) | 2015-09-30 | 2021-03-09 | Shionogi & Co., Ltd. | Nucleic acid derivative having immunostimulatory activity |
| JP6583864B2 (ja) * | 2015-09-30 | 2019-10-09 | 塩野義製薬株式会社 | 免疫賦活活性を有する核酸誘導体 |
| EP3364949A4 (en) | 2015-10-22 | 2019-07-31 | ModernaTX, Inc. | CANCER VACCINES |
| US11623002B2 (en) * | 2016-01-29 | 2023-04-11 | Elicio Therapeutics, Inc. | ALK polypeptides and methods of use thereof |
| WO2017139570A1 (en) | 2016-02-12 | 2017-08-17 | Massachusetts Intitute Of Technology | Synergistic tumor treatment with il-2, an integrin-binding-fc fusion protein, and a cancer vaccinne |
| WO2017155981A1 (en) | 2016-03-07 | 2017-09-14 | Massachusetts Institute Of Technology | Protein-chaperoned t-cell vaccines |
| EP3436031A4 (en) | 2016-04-01 | 2019-09-18 | Vycellix, Inc. | Novel RNA construct and method of use therefor for increasing the therapeutic effects of cytotoxic cells and stem cells |
| EP3440013A4 (en) * | 2016-04-08 | 2021-03-17 | Massachusetts Institute of Technology | METHOD FOR SPECIFIC PROFILING OF PROTEASE ACTIVITY ON LYMPH NODES |
| WO2017192874A1 (en) | 2016-05-04 | 2017-11-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Albumin-binding immunomodulatory compositions and methods of use thereof |
| WO2017193070A1 (en) | 2016-05-05 | 2017-11-09 | Massachusetts Institute Of Technology | Methods and uses for remotely triggered protease activity measurements |
| WO2018013924A1 (en) | 2016-07-15 | 2018-01-18 | Massachusetts Institute Of Technology | Synthetic nanoparticles for delivery of immunomodulatory compounds |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| CA2954115C (en) * | 2016-10-16 | 2022-04-12 | Neil Gordon | Ultra-sensitive bioanalyte quantification from self-assembled quadruplex tags |
| SG11201908059YA (en) * | 2017-03-29 | 2019-10-30 | Shionogi & Co | Nucleic acid derivative having immunostimulatory activity |
| JP2020515629A (ja) | 2017-04-04 | 2020-05-28 | アヴィディア テクノロジーズ, インコーポレイテッド | 免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用 |
| AU2018248327B2 (en) | 2017-04-07 | 2024-10-10 | Massachusetts Institute Of Technology | Methods to spatially profile protease activity in tissue and sections |
| NL2018803B1 (en) * | 2017-04-27 | 2018-11-05 | Academisch Ziekenhuis Leiden Handelend Onder De Naam Leids Univ Medisch Centrum/ H O D N Lumc | Adjuvant compounds |
| WO2018201090A1 (en) | 2017-04-28 | 2018-11-01 | Exicure, Inc. | Synthesis of spherical nucleic acids using lipophilic moieties |
| JP2020526558A (ja) | 2017-07-13 | 2020-08-31 | ノースウェスタン ユニバーシティ | オリゴヌクレオチド官能化金属有機構造体ナノ粒子を調製するための一般的かつ直接的な方法 |
| CN111164104A (zh) * | 2017-08-09 | 2020-05-15 | 麻省理工学院 | 白蛋白结合肽缀合物及其方法 |
| US20190046649A1 (en) * | 2017-08-09 | 2019-02-14 | University Of Maryland, Baltimore County | Delivery device and use thereof for loading cell plasma membranes |
| CA3076337A1 (en) | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| CN111601900A (zh) * | 2017-11-02 | 2020-08-28 | 詹森生物制药有限公司 | 寡核苷酸构建体及其用途 |
| PL3700564T3 (pl) * | 2017-12-15 | 2026-02-23 | Elanco Animal Health Gmbh | Kompozycje immunostymulujące |
| KR102787353B1 (ko) | 2018-03-02 | 2025-03-26 | 엘리시오 테라퓨틱스, 인크. | 돌연변이 kras 서열 및 지질을 포함하는 화합물 및 이의 용도 |
| WO2019173332A1 (en) | 2018-03-05 | 2019-09-12 | Massachusetts Institute Of Technology | Inhalable nanosensors with volatile reporters and uses thereof |
| CA3098623A1 (en) | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| WO2020055503A1 (en) | 2018-09-14 | 2020-03-19 | Massachusetts Institute Of Technology | Nanoparticle vaccine adjuvant and methods of use thereof |
| EP3856921B1 (en) | 2018-09-25 | 2026-04-29 | Massachusetts Institute Of Technology | Lung protease nanosensors and uses thereof |
| SG11202100935TA (en) | 2018-09-28 | 2021-02-25 | Massachusetts Inst Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| JP2022505318A (ja) * | 2018-10-18 | 2022-01-14 | ドイチェス クレブスフォルシュンクスツェントルム | 吸入用乾燥医薬組成物 |
| EP3911753A1 (en) | 2019-01-17 | 2021-11-24 | Massachusetts Institute of Technology | Sensors for detecting and imaging of cancer metastasis |
| WO2020154032A1 (en) | 2019-01-23 | 2020-07-30 | Massachusetts Institute Of Technology | Combination immunotherapy dosing regimen for immune checkpoint blockade |
| US11504425B2 (en) | 2019-02-26 | 2022-11-22 | Wayne State University | Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers |
| US12702719B2 (en) | 2019-03-06 | 2026-08-11 | Northwestern University | Hairpin-like oligonucleotide-conjugated spherical nucleic acid |
| JP2022525781A (ja) * | 2019-03-20 | 2022-05-19 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫細胞療法における両親媒性物質の使用およびそのための組成物 |
| WO2020246443A1 (ja) | 2019-06-03 | 2020-12-10 | 塩野義製薬株式会社 | 二分岐脂質結合オリゴヌクレオチドの製造方法及び中間体 |
| JP2022538974A (ja) | 2019-06-26 | 2022-09-07 | マサチューセッツ インスチテュート オブ テクノロジー | 免疫調節融合タンパク質-金属水酸化物錯体およびその方法 |
| CN110483706B (zh) * | 2019-07-11 | 2021-10-12 | 江苏大学 | 一种基于寡核苷酸双亲性温敏性嵌段聚合物双功能荧光探针的制备方法及应用 |
| US12319711B2 (en) | 2019-09-20 | 2025-06-03 | Northwestern University | Spherical nucleic acids with tailored and active protein coronae |
| US12378560B2 (en) | 2019-10-29 | 2025-08-05 | Northwestern University | Sequence multiplicity within spherical nucleic acids |
| US12433954B2 (en) | 2020-05-01 | 2025-10-07 | Massachusetts Institute Of Technology | Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs |
| US20210340524A1 (en) | 2020-05-01 | 2021-11-04 | Massachusetts Institute Of Technology | Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof |
| CA3183735A1 (en) * | 2020-06-26 | 2021-12-30 | Martin P. STEINBUCK | Compositions and methods for inducing an immune response against coronavirus |
| CN116507344A (zh) * | 2020-06-26 | 2023-07-28 | 伊莱西奥治疗有限公司 | 用于诱导针对冠状病毒的免疫应答的组合物和方法 |
| KR20230107553A (ko) * | 2020-10-07 | 2023-07-17 | 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 | 헤르페스바이러스 폴리에피토프 백신 |
| US20240423972A1 (en) | 2021-02-01 | 2024-12-26 | Yale University | Chemotherapeutic bioadhesive particles with immunostimulatory molecules for cancer treatment |
| CA3211565A1 (en) * | 2021-03-10 | 2022-09-15 | Dylan DRAKES | Uses of amphiphiles in immune cell therapy and compositions therefor |
| EP4304640A1 (en) | 2021-03-12 | 2024-01-17 | Northwestern University | Antiviral vaccines using spherical nucleic acids |
| US20250188455A1 (en) * | 2021-09-02 | 2025-06-12 | Vanderbilt University | Lipophilic oligonucleotide conjugates |
| WO2023114570A1 (en) | 2021-12-19 | 2023-06-22 | Massachusetts Institute Of Technology | Compositions and methods for long-lasting germinal center responses to a priming immunization |
| US20230414763A1 (en) | 2022-03-04 | 2023-12-28 | Massachusetts Institute Of Technology | Transmucosal amphiphile-protein conjugate vaccine |
| CN115590974A (zh) * | 2022-05-27 | 2023-01-13 | 苏州大学(Cn) | 功能化靶向制剂及其制备方法、应用 |
| AU2023367780A1 (en) | 2022-10-25 | 2025-03-27 | Barinthus Biotherapeutics North America, Inc. | Self-assembling nanoparticles |
| JP2026519945A (ja) * | 2023-04-26 | 2026-06-19 | エリシオ セラピューティクス, インク. | ポリヌクレオチド及びポリペプチド両親媒性物質を含有する組成物並びにその使用方法 |
| CN118557712A (zh) * | 2024-05-15 | 2024-08-30 | 苏州大学 | 靶向型免疫耐受性疫苗及其制备方法与用途 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| JP2528107B2 (ja) | 1985-03-15 | 1996-08-28 | サマ−トン,ジエ−ムス | ポリヌクレオチド測定試薬と方法 |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5256641A (en) | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
| FR2670787B1 (fr) * | 1990-12-18 | 1995-06-23 | Pasteur Institut | Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins. |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
| US6056973A (en) | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| US5786571A (en) | 1997-05-09 | 1998-07-28 | Lexmark International, Inc. | Wrapped temperature sensing assembly |
| AU2001268427B2 (en) * | 2000-06-16 | 2007-03-29 | Glaxosmithkline Intellectual Property Limited | Antibodies that immunospecifically bind to blys |
| US7563618B2 (en) | 2001-03-23 | 2009-07-21 | Geron Corporation | Oligonucleotide conjugates |
| AU2003203079B9 (en) | 2002-02-04 | 2009-01-15 | Oncothyreon Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| JP4989225B2 (ja) | 2003-09-25 | 2012-08-01 | コーリー ファーマシューティカル グループ,インコーポレイテッド | 核酸親油性接合体 |
| GB0412181D0 (en) * | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
| US8124128B2 (en) | 2005-11-08 | 2012-02-28 | Industrial Technology Research Institute | Amphiphilic block copolymers and nano particles comprising the same |
| US20070154398A1 (en) | 2005-12-30 | 2007-07-05 | Industrial Technology Research Institute | Block copolymers and nano micelles comprising the same |
| EP2104738A2 (en) * | 2006-10-26 | 2009-09-30 | Coley Pharmaceuticals GmbH | Oligoribonucleotides and uses thereof |
| TWM320264U (en) | 2006-12-08 | 2007-10-01 | P Two Ind Inc | Multi-band frequency-selective filter |
| EP2510946B1 (en) | 2007-02-07 | 2015-08-05 | The Regents of The University of California | Conjugates of synthetic tlr agonists and uses therefor |
| ATE530169T1 (de) | 2007-09-28 | 2011-11-15 | Bind Biosciences Inc | Krebszellen-targeting mit nanopartikeln |
| WO2010071852A2 (en) | 2008-12-19 | 2010-06-24 | University Of Florida Research Foundation, Inc. | Oligonucleotide micelles |
| DK2424562T3 (en) * | 2009-04-30 | 2015-12-07 | Coley Pharm Group Inc | Pneumococcal vaccine and uses thereof |
| ES2731343T3 (es) * | 2009-05-19 | 2019-11-15 | Univ Miami | Composiciones, kits y métodos para presentación de antígenos in vitro, evaluación de eficacia de vacunas y evaluación de la inmunotoxicidad de productos biológicos y fármacos |
| TWI397428B (zh) | 2009-12-29 | 2013-06-01 | 財團法人工業技術研究院 | 標的第四介白素受體之傳輸系統 |
| ES2983470T3 (es) * | 2010-03-19 | 2024-10-23 | Takeda Pharmaceuticals Co | Inhibidores del TFPI y métodos de uso |
| EP2575868A1 (en) * | 2010-06-07 | 2013-04-10 | Pfizer Vaccines LLC | Ige ch3 peptide vaccine |
| JP5897035B2 (ja) | 2010-12-14 | 2016-03-30 | ユニバーシティ オブ メリーランド,ボルチモア | 汎用の抗タグキメラ抗原受容体発現t細胞及びがんを治療する方法 |
| BR112013030104A8 (pt) * | 2011-05-25 | 2021-09-08 | Camurus Ab | Pré-formulação, processo para a formação de uma pré-formulação, método de tratamento cosmético, dispositivo de administração preenchido, e, kit |
| WO2013022982A2 (en) * | 2011-08-09 | 2013-02-14 | Atyr Pharma, Inc. | Pegylated tyrosyl-trna synthetase polypeptides |
| US20150044208A1 (en) * | 2011-09-23 | 2015-02-12 | Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, Sa | Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics |
| JP6375289B2 (ja) * | 2012-04-05 | 2018-08-15 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫刺激組成物およびその使用方法 |
| IN2014DN10889A (cg-RX-API-DMAC10.html) | 2012-07-13 | 2015-09-11 | Univ Pennsylvania | |
| US9694050B2 (en) * | 2012-10-21 | 2017-07-04 | University Of Rochester | THY1 (CD90) as a novel therapy to control adipose tissue accumulation |
| KR102109188B1 (ko) * | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| EP3650038A1 (en) | 2013-06-19 | 2020-05-13 | Massachusetts Institute of Technology | In vivo targeting of cells with ligand-conjugated particles |
| AU2014337367B2 (en) | 2013-10-15 | 2020-04-30 | The Scripps Research Institute | Peptidic chimeric antigen receptor T cell switches and uses thereof |
| JP6413404B2 (ja) | 2014-07-07 | 2018-10-31 | カシオ計算機株式会社 | 電子機器、位置推定方法及びプログラム |
| US20160228573A1 (en) | 2014-08-14 | 2016-08-11 | L.E.A.F. Holdings Group Llc | Liposome encapsulated affinity drug |
| RU2716716C2 (ru) | 2014-10-27 | 2020-03-16 | Фред Хатчинсон Кэнсер Рисёрч Сентер | Композиции и способы для бустинга эффективности адоптивной клеточной иммунотерапии |
| AU2016274989A1 (en) | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| WO2017035009A1 (en) | 2015-08-21 | 2017-03-02 | The Methodist Hospital | Cationic liposomes for cancer immunotherapy |
| US11370826B2 (en) | 2016-02-09 | 2022-06-28 | Bracco Suisse Sa | Recombinant chimeric protein for selectins targeting |
| US20170224797A1 (en) | 2016-02-10 | 2017-08-10 | Xeme Biopharma Inc. | Cancer Therapy Using a Vaccine in Combination with a Cell-Based Immunotherapeutic Agent |
| JP6884155B2 (ja) | 2016-02-18 | 2021-06-09 | エンリヴェックス セラピューティクス リミテッド | 癌治療のための併用免疫療法及びサイトカイン制御療法 |
| US20180028634A1 (en) | 2016-07-29 | 2018-02-01 | Lan Bo Chen | Method for prolonging and enhancing anti-tumor vaccine response |
| EP3672636A4 (en) | 2017-08-23 | 2021-05-12 | Brown University | PROCEDURES AND COMPOSITIONS RELATED TO ANTI-CHI3L1 ANTIBODY REAGENTS |
| CA3076337A1 (en) | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| JP2022525781A (ja) | 2019-03-20 | 2022-05-19 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫細胞療法における両親媒性物質の使用およびそのための組成物 |
| WO2023224715A1 (en) | 2022-05-19 | 2023-11-23 | Massachusetts Institute Of Technology | Car cells targeting an inserted ligand |
-
2013
- 2013-03-15 JP JP2015504601A patent/JP6375289B2/ja active Active
- 2013-03-15 WO PCT/US2013/032600 patent/WO2013151771A1/en not_active Ceased
- 2013-03-15 EP EP13715498.5A patent/EP2833918B1/en active Active
- 2013-03-15 ES ES13715498T patent/ES2731524T3/es active Active
- 2013-03-15 US US13/844,075 patent/US9107904B2/en active Active
- 2013-03-15 EP EP19160590.6A patent/EP3563872A1/en active Pending
-
2015
- 2015-07-02 US US14/790,432 patent/US10029016B2/en active Active
-
2017
- 2017-04-11 JP JP2017078218A patent/JP2017165739A/ja active Pending
-
2018
- 2018-07-19 US US16/040,181 patent/US10953105B2/en active Active
-
2020
- 2020-06-08 JP JP2020099145A patent/JP2020143165A/ja active Pending
-
2021
- 2021-03-05 US US17/193,999 patent/US12303566B2/en active Active
-
2022
- 2022-10-14 JP JP2022165307A patent/JP7631277B2/ja active Active
-
2025
- 2025-01-17 US US19/031,093 patent/US20250195674A1/en not_active Abandoned
- 2025-02-05 JP JP2025017374A patent/JP2025072507A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moura et al. | Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders | |
| JP6367554B2 (ja) | アジュバント化合成ナノキャリアの投与量選択 | |
| JP2022543038A5 (cg-RX-API-DMAC10.html) | ||
| US8323696B2 (en) | Nanoparticles for immunotherapy | |
| WO2008056654A1 (fr) | Dérivé polymère d'un antagoniste métabolique d'acide nucléique | |
| CN102333541B (zh) | 免疫原性组合物 | |
| JP6267155B2 (ja) | 多価アジュバントディスプレイ | |
| JP2020535128A5 (cg-RX-API-DMAC10.html) | ||
| JP2017521045A5 (cg-RX-API-DMAC10.html) | ||
| JP2015163617A (ja) | ワクチン | |
| US20130295129A1 (en) | Immunostimulatory compositions and methods of use thereof | |
| CN105188764B (zh) | Dna嵌入剂的细胞递送 | |
| TW200307557A (en) | Stabilized synthetic immunogen delivery systems | |
| JP2010529214A (ja) | カチオン性基及び疎水性基により官能基化したポリグルタミン酸及びその応用、特にはその治療への応用 | |
| WO2000047186A1 (en) | Polynucleotide compositions for intramuscular and intradermal administration | |
| CA2297101A1 (en) | Receptor specific transepithelial transport of therapeutics | |
| JP2009524584A (ja) | ポリマー−生物製剤送達組成物を構築するための方法 | |
| KR20140024833A (ko) | 신규한 시티딘계 대사길항제의 고분자 유도체 | |
| US20240075132A1 (en) | Immunity-inducing agent and pharmaceutical composition containing same | |
| KR20240054288A (ko) | 면역원성 증강용 조성물 | |
| CN112707943A (zh) | 结合5′-末端缀合物和中性/阳离子混合脂材包载的小干扰rna及其修饰方法 | |
| Xi et al. | Recent advances in the design of self‐delivery amphiphilic drugs and vaccines | |
| Yu et al. | Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery | |
| Jabbari | Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles | |
| Rai et al. | Functionalisation of dendrimers |